Accordingly, the objectives of this study were to characterize the effects of youth-onset T2D on kidney structure and function and understand the impact of SGLT2 inhibition on the morphological and molecular features of early kidney injury. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.